Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Jan;51(1):125-30.
doi: 10.1128/JCM.02010-12. Epub 2012 Oct 24.

A novel, sensitive assay for high-throughput molecular detection of plasmodia for active screening of malaria for elimination

Affiliations
Comparative Study

A novel, sensitive assay for high-throughput molecular detection of plasmodia for active screening of malaria for elimination

Zhibin Cheng et al. J Clin Microbiol. 2013 Jan.

Abstract

Although malaria remains one of the leading infectious diseases in the world, the decline in malaria transmission in some area makes it possible to consider elimination of the disease. As countries approach elimination, malaria diagnosis needs to change from diagnosing ill patients to actively detecting infections in all carriers, including asymptomatic and low-parasite-load patients. However, few of the current diagnostic methods have both the throughput and the sensitivity required. We adopted a sandwich RNA hybridization assay to detect genus Plasmodium 18S rRNA directly from whole-blood samples from Plasmodium falciparum and Plasmodium vivax patients without RNA isolation. We tested the assay with 202 febrile patients from areas where malaria is endemic, using 20 μl of each blood sample in a 96-well plate format with a 2-day enzyme-linked immunosorbent assay (ELISA)-like work flow. The results were compared with diagnoses obtained using microscopy, a rapid diagnostic test (RDT), and genus-specific real-time PCR. Our assay identified all 66 positive samples diagnosed by microscopy, including 49 poorly stored samples that underwent multiple freeze-thaw cycles due to resource limitation. The assay uncovered three false-negative samples by microscopy and four false-negative samples by RDT and agreed completely with real-time PCR diagnosis. There was no negative sample by our assay that would show a positive result when tested with other methods. The detection limit of our assay for P. falciparum was 0.04 parasite/μl. The assay's simple work flow, high throughput, and sensitivity make it suitable for active malaria screening.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Correlation of assay signal with cultured Plasmodium falciparum parasitemia in human erythrocytes. Parasitemia in human erythrocyte culture was determined based on infection rate (number of infected red blood cells [RBCs]/number of infected plus uninfected RBCs [n = 1,000]) and RBC concentration The limit of detection was determined as the minimal amount of cultured plasmodia added to the erythrocytes that gave a net signal above three times the SD of the background erythrocyte control (dashed line). Each dilution was prepared using culture medium. Triplicate samples were used in the assay, and the data are representative of three independent runs. The average limit of detection was 0.04 parasite/μl blood. RLU, relative light units.
Fig 2
Fig 2
Correlation between assay signal and parasitemia for poorly stored blood samples. Stored blood samples from 49 patients, which underwent multiple freeze-and-thaw cycles after collection due to limited resources, were assayed (20 μl each), and the net signals were plotted against parasitemia determined microscopically at admission. Each sample was assayed in duplicate, and the average signal was used. Signal intensities beyond 1 × 107 RLU were considered approaching detection saturation of the photon detector.

References

    1. Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, Doumbo OK, Greenwood B, Hall BF, Levine MM, Mendis K, Newman RD, Plowe CV, Rodriguez MH, Sinden R, Slutsker L, Tanner M. 2011. A research agenda to underpin malaria eradication. PLoS Med. 8: e1000406 doi:10.1371/journal.pmed.1000406 - DOI - PMC - PubMed
    1. Feachem RG, Phillips AA, Targett GA, Snow RW. 2010. Call to action: priorities for malaria elimination. Lancet 376:1517– 1521 - PMC - PubMed
    1. Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, Hay SI, Snow RW. 2008. The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med. 5: e38 doi:10.1371/journal.pmed.0050038 - DOI - PMC - PubMed
    1. Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, Boaz L, Lilley K, Krause D, Vallely A, Johnson ML, Gatton ML, Shanks GD, Cheng Q. 2010. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar. J. 9:254. - PMC - PubMed
    1. Ogutu B, Tiono AB, Makanga M, Premji Z, Gbadoe AD, Ubben D, Marrast AC, Gaye O. 2010. Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Malar. J. 9:30. - PMC - PubMed

Publication types

MeSH terms